STOCK TITAN

Anterix (ATEX) SEC Filings

ATEX NASDAQ

Anterix Inc. filings document the company’s 900 MHz private wireless broadband spectrum business, including material-event reports on spectrum license sale agreements, operating and financial results, Regulation FD updates, and capital-structure disclosures. The records include disclosures tied to broadband license sales, narrowband-to-broadband license exchanges, spectrum clearing costs, contracted proceeds, and the Demonstrated Intent key performance indicator.

The company’s SEC filings also cover governance matters, executive compensation and severance arrangements, shareholder voting matters, risk factors, and regulatory developments affecting broadband use of the 900 MHz band. Material agreements involving its wholly owned subsidiary, PDV Spectrum Holding Company, LLC, are documented through Form 8-K exhibits and related event disclosures.

Rhea-AI Summary

Anterix Inc. common stock was the subject of a beneficial-ownership report by BlackRock, Inc., which reported 914,372 shares, or 4.7% of the class. BlackRock reported sole voting power over 892,350 shares and sole dispositive power over 914,372 shares, with no shared voting or dispositive power. The reported position reflects certain BlackRock business units and affiliates; other units whose ownership is disaggregated are excluded.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.72%
Tags
ownership
-
Rhea-AI Summary

Anterix Inc. Chief Financial Officer Elena Marquez exercised options to acquire 1,227 common shares at $40 per share on October 9, 2026, and sold 4,981 shares that day under a Rule 10b5-1 trading plan adopted June 22, 2026. The sales were 3,254 shares at a weighted average price of $80.1627, 400 at a weighted average price of $81.8000, 100 at $82.5000, 1,017 at a weighted average price of $80.2247, and 210 at a weighted average price of $81.8993.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
insider
-
Rhea-AI Summary

Anterix Inc. (ATEX) officer Elena Marquez proposes to sell 4,981 common shares, with an aggregate market value of $400,606.71 and an approximate sale date of October 9, 2026. Morgan Stanley Smith Barney LLC is named in the broker field. The securities table lists 3,754 shares acquired as restricted stock and 1,227 shares from a stock option exercise.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.51%
Tags
other
Rhea-AI Summary

Anterix Inc. (ATEX) Chief Financial Officer Elena Marquez reported that 473 shares were withheld by the issuer on October 5, 2026, to satisfy tax-withholding obligations in connection with partial vesting and settlement of restricted stock units. Her directly held position afterward was 16,358 shares. No Rule 10b5-1 plan is reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.67%
Tags
insider
-
Rhea-AI Summary

Anterix Inc. Chief Financial Officer Elena Marquez had 1,325 shares of common stock withheld by the issuer on September 29, 2026, to satisfy withholding obligations connected with the partial vesting and settlement of restricted stock units. After the transaction, she held 16,831 common shares directly. The reported price per share was $81.75.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.68%
Tags
insider
-
Rhea-AI Summary

Anterix Inc. (ATEX) President and CEO Scott A. Lang sold 15,000 shares of common stock on September 21, 2026, at $80 per share. The sale was made under a Rule 10b5-1(c) trading plan adopted June 22, 2026. After the transaction, Lang directly held 26,470 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.48%
Tags
insider
Rhea-AI Summary

Anterix Inc. (ATEX) reported that President and CEO, and director, Scott A. Lang sold 15,000 shares of common stock on September 21, 2026 in a sale characterized as an open market or private transaction at $80.00 per share. Following this transaction, he directly holds 26,470 shares of Anterix common stock, and no Rule 10b5-1 trading plan is reported in connection with this sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.48%
Tags
insider
-
Rhea-AI Summary

Anterix Inc. (ATEX) received a notice that Scott Lang plans to sell up to 15,000 shares of Anterix common stock under Rule 144 through Morgan Stanley Smith Barney LLC. These shares relate to an option exercise dated June 15, 2026, with the issuer listed as the source of the shares.

The proposed sale has an aggregate value of $1,200,000, based on the market information provided as of September 21, 2026, when 19,609,786 common shares were outstanding. Over the prior three months, Scott Lang sold 35,057 Anterix common shares for total consideration of $3,162,733.86.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.94%
Tags
other
-
Rhea-AI Summary

Anterix Inc. (ATEX) announced that its Board of Directors authorized a new share repurchase program effective September 22, 2026, following the expiration of its prior program on September 21, 2026. Under this program, the company may repurchase up to $250,000,000 of its common stock on or before September 22, 2029.

The company may buy back shares on the open market and through privately negotiated transactions, potentially using Rule 10b5-1 trading plans. The timing and amount of repurchases will depend on business and market conditions and other strategic factors, and the program can be suspended, discontinued, or modified at any time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.61%
Tags
current report
Rhea-AI Summary

Anterix Inc. (ATEX) reported that officer Martin Heather, Chief Marketing Officer and Chief of Staff, disposed of common stock in two transactions. On September 9, 2026, 3,465 shares were withheld to satisfy tax obligations upon partial vesting of restricted stock units. On September 10, 2026, 8,064 shares were sold in an open-market or private transaction at a weighted average price of $84.2011 per share, with individual sale prices ranging from $84.00 to $84.468. No Rule 10b5-1 trading plan is indicated.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.59%
Tags
insider

FAQ

How many Anterix (ATEX) SEC filings are available on StockTitan?

StockTitan tracks 104 SEC filings for Anterix (ATEX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Anterix (ATEX)?

The most recent SEC filing for Anterix (ATEX) was filed on October 27, 2026.